Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007–10) and role of an efflux pump in tigecycline non-susceptibility
Authors:
Open Access
- 18 January 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 68 (5) , 1036-1042
Abstract
To investigate the trend of tigecycline susceptibility and mechanisms behind tigecycline non-susceptibility in Klebsiella pneumoniae and Escherichia coli isolates causing neonatal septicaemia (2007–10). MICs of tigecycline for the isolates were determined. The isolates were evaluated for β-lactamases and carbapenemases. Molecular typing of the tigecycline-resistant isolates was performed. Expression of efflux pump genes (acrA, acrB and tolC) and regulators (soxS and ramA) was examined by real-time RT–PCR and western blotting. Sequencing of the ramA and ramR genes was carried out to identify mutations within these genes. Tigecycline susceptibility was evaluated in all K. pneumoniae (n = 57) and E. coli (n = 19) blood isolates. The prevalence of extended-spectrum β-lactamase (ESBL)-producing organisms was high, but tigecycline non-susceptibility remained low in these isolates. Though MIC values of tigecycline remained in the susceptible range, there was a 2-fold increase in the value of MIC90 from 2007 to 2010. Over the 4 year period K. pneumoniae showed higher MIC values of tigecycline in comparison with E. coli. Tigecycline non-susceptibility was not observed among carbapenem-resistant isolates. Only two ESBL-producing clonally distinct K. pneumoniae isolates showed tigecycline resistance with overexpression of ramA and the AcrAB–TolC pump. No mutations were present within the ramA and ramR genes that might enhance the expression of the pump. The study showed for the first time the trend of tigecycline susceptibility in E. coli and K. pneumoniae causing neonatal septicaemia. Tigecycline still has potent antimicrobial effects against most ESBL- or carbapenemase-producing K. pneumoniae and E. coli, but the increasing MIC values make it essential to be vigilant.Keywords
This publication has 25 references indexed in Scilit:
- Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the Tigecycline In Vitro Surveillance in Taiwan Study, 2006 to 2010Antimicrobial Agents and Chemotherapy, 2012
- Current Epidemiology and Growing Resistance of Gram-Negative PathogensThe Korean Journal of Internal Medicine, 2012
- Transmission of imipenem resistance determinants during the course of an outbreak of NDM-1 Escherichia coli in a sick newborn care unitJournal of Antimicrobial Chemotherapy, 2011
- Genetic regulation of the ramA locus and its expression in clinical isolates of Klebsiella pneumoniaeInternational Journal of Antimicrobial Agents, 2011
- ramR Mutations in Clinical Isolates of Klebsiella pneumoniae with Reduced Susceptibility to TigecyclineAntimicrobial Agents and Chemotherapy, 2010
- The C-Terminal Domain of AcrA Is Essential for the Assembly and Function of the Multidrug Efflux Pump AcrAB-TolCJournal of Bacteriology, 2009
- Emergence of carbapenem-non-susceptible extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, GermanyJournal of Medical Microbiology, 2009
- Pathogens Associated With Sepsis in Newborns and Young Infants in Developing CountriesThe Pediatric Infectious Disease Journal, 2009
- Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levelsJournal of Antimicrobial Chemotherapy, 2008
- Antibiotic Stress, Genetic Response and Altered Permeability of E. coliPLOS ONE, 2007